Pharmacological Modulation of Cortical Perfusion
Corresponding Organization :
Other organizations : University of Szeged
Variable analysis
- Drug solutions or vehicle of equal volume (1.5% DMSO in 10 ml aCSF) superfused on the cortical surface
- The selective COX-2 inhibitor NS-398 (100 μM)
- The selective COX-1 inhibitor SC-560 (25 μM)
- The selective PGE2 receptor (EP4) antagonist L161,982 (1 μM)
- DC potential
- CBF (Cerebral Blood Flow)
- Baseline measurements taken for 5 min under aCSF prior to drug application
- Pharmacological treatment initiated 40 min prior to ischemia induction or the elicitation of the first SD event in the sham-operated group
- Positive control: Vehicle of equal volume (1.5% DMSO in 10 ml aCSF) superfused on the cortical surface
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!